✦ LIBER ✦

Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: basis for a new classification

✍ Scribed by G. Bussolati; M. Bongiovanni; P. Cassoni; A. Sapino

Publisher: Springer
Year: 2000
Tongue: English
Weight: 209 KB
Volume: 437
Category: Article
ISSN: 1432-2307
DOI: 10.1007/s004280000267

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ductal carcinoma in situ of the breast

✍ Harris, Jules E. ;Bruetman, Daniel ;Bloom, Ken ;Bines, Steven 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

Assessment of treatment for patients wit

Assessment of treatment for patients with primary ductal carcinoma in situ in the breast

✍ Edward B. Fish; Judy-Anne W. Chapman; Naomi A. Miller; Marilyn A. Link; Eve Fish 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 909 KB

Ductal carcinoma in situ of the male bre

Ductal carcinoma in situ of the male breast

✍ Mauricio G. Camus; Megha G. Joshi; Gasan Mackarem; Arthur K. C. Lee; Ricardo L. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr

A prognostic index for ductal carcinoma

A prognostic index for ductal carcinoma in situ of the breast

✍ Melvin J. Silverstein; Michael D. Lagios; Pamela H. Craig; James R. Waisman; Ber 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 663 KB

## BACKGROUND. There is controversy and confusion regarding therapy for patients with ductal carcinoma in situ (DCIS) of the breast. The Van Nuys Prognostic Index (VNPI) was developed to aid in the complex treatment selection process.

Heterogeneity of ductal carcinoma in sit

Heterogeneity of ductal carcinoma in situ of the breast

✍ Michael D. Lagios 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 1 views

Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents

Treatment of ductal carcinoma in situ of

Treatment of ductal carcinoma in situ of the breast

✍ Michael M. Moore 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

## Abstract Ductal carcinoma in situ (DCIS) is increasing in frequency, primarily because of the increasing use of routine screening mammography. The management of DCIS has become one of the more controversial aspects in the treatment of breast cancer. Although total mastectomy provides local contr